UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Phosphorylation of LXRα impacts atherosclerosis regression by modulating monocyte trafficking

Shrestha, E; Voisin, M; Barret, T; Nishi, H; Cantor, D; Hissein, M; David, G; ... Garabedian, M; + view all (2018) Phosphorylation of LXRα impacts atherosclerosis regression by modulating monocyte trafficking. bioRxiv 10.1101/363366. Green open access

[thumbnail of Pineda Torra_Phosphorylation of LXRα impacts atherosclerosis regression by modulating monocyte trafficking_AM.pdf]
Preview
Text
Pineda Torra_Phosphorylation of LXRα impacts atherosclerosis regression by modulating monocyte trafficking_AM.pdf

Download (1MB) | Preview

Abstract

LXRα activation in macrophages enhances regression of atherosclerotic plaques in mice by regulating genes crucial for cholesterol efflux, cell motility and inflammation. Diabetes, however, impairs plaque regression in mice. LXRα is phosphorylated at serine 198 (pS198), which affects the expression of genes controlling inflammation, lipid metabolism and cell movement. We hypothesize that LXRα function is affected by hyperglycemia through changes in LXRα pS198. Indeed, macrophages cultured in diabetes relevant high glucose versus normal glucose display alterations in LXR-dependent gene expression and increased LXRα pS198. We therefore examined the consequence of disrupting LXRα phosphorylation (S196A in mouse LXRα) during regression of atherosclerosis in normal and diabetic mice. We find that phosphorylation deficient LXRα S196A reduces macrophage retention in plaques in diabetes, which is predicted to be anti-atherogenic and enhance plaque regression. However, this favorable effect on regression is masked by increased monocyte infiltration in the plaque attributed to leukocytosis in LXRα S196A mice. RNA-seq of plaque macrophages from diabetic S196A mice shows increased expression of chemotaxis and decreased expression of cell adhesion genes, consistent with reduced macrophage retention by LXRα S196A. Thus, the non-phosphorylated form of LXRα precludes macrophage retention in the plaque. Our study provides the first evidence for a physiological role of LXRα phosphorylation in modulating atherosclerosis regression. Compounds that prevent LXRα phosphorylation or ligands that induce the conformation of non-phosphorylated LXRα may selectively enhance macrophage emigration from atherosclerotic plaques.

Type: Article
Title: Phosphorylation of LXRα impacts atherosclerosis regression by modulating monocyte trafficking
Open access status: An open access version is available from UCL Discovery
DOI: 10.1101/363366
Publisher version: https://doi.org/10.1101/363366
Language: English
Additional information: The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Keywords: LXR, Phosphorylation, Atherosclerosis
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10060720
Downloads since deposit
1,848Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item